Trial · NCT02709746
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase A (Single-blind Treatment Period) | STARTED | Single-blind Treatment, Placebo | 784 | |
| Phase A (Single-blind Treatment Period) | STARTED | DBT, Vortioxetine 10 mg | 0 | |
| Phase A (Single-blind Treatment Period) | STARTED | DBT, Vortioxetine 20 mg | 0 | |
| Phase A (Single-blind Treatment Period) | STARTED | DBT, Fluoxetine 20 mg | 0 | |
| Phase A (Single-blind Treatment Period) | STARTED | DBT, Placebo | 0 | |
| Phase A (Single-blind Treatment Period) | COMPLETED | Single-blind Treatment, Placebo | 616 | |
| Phase A (Single-blind Treatment Period) | COMPLETED | DBT, Vortioxetine 10 mg | 0 | |
| Phase A (Single-blind Treatment Period) | COMPLETED | DBT, Vortioxetine 20 mg | 0 | |
| Phase A (Single-blind Treatment Period) | COMPLETED | DBT, Fluoxetine 20 mg | 0 | |
| Phase A (Single-blind Treatment Period) | COMPLETED | DBT, Placebo | 0 | |
| Phase A (Single-blind Treatment Period) | NOT COMPLETED | Single-blind Treatment, Placebo | 168 | |
| Phase A (Single-blind Treatment Period) | NOT COMPLETED | DBT, Vortioxetine 10 mg | 0 | |
| Phase A (Single-blind Treatment Period) | NOT COMPLETED | DBT, Vortioxetine 20 mg | 0 | |
| Phase A (Single-blind Treatment Period) | NOT COMPLETED | DBT, Fluoxetine 20 mg | 0 | |
| Phase A (Single-blind Treatment Period) | NOT COMPLETED | DBT, Placebo | 0 | |
| Phase B (Double-blind Treatment Period) | STARTED | Single-blind Treatment, Placebo | 0 | |
| Phase B (Double-blind Treatment Period) | STARTED | DBT, Vortioxetine 10 mg | 147 | |
| Phase B (Double-blind Treatment Period) | STARTED | DBT, Vortioxetine 20 mg | 162 | |
| Phase B (Double-blind Treatment Period) | STARTED | DBT, Fluoxetine 20 mg | 153 | |
| Phase B (Double-blind Treatment Period) | STARTED | DBT, Placebo | 154 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02709746/flow